Elevance Health Inc (ELV)
Official siteHEALTHCARE • HEALTHCARE PLANS • NYSE
Market Cap: $92.84B
Last updated: Nov 17, 2026 at 11:05 AM ET
Elevance Health Inc (ELV) P/E Ratio & Valuation History
Elevance Health (ELV) trades at 14.7x trailing earnings and 0.5x sales. Its P/E of 14.7x is above its 5-year median of 14.4x. Its forward P/E is 14.3x. The median P/E across 12 similar companies is 29.2x.
Current Multiples
Its forward P/E is below its trailing P/E, which implies earnings per share about 2.8% higher over the next year. Its free cash flow yield is 6.8%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 14.7x |
| Forward P/E | 14.3x |
| Price to sales | 0.5x |
| Price to book | 2.2x |
| EV/EBITDA | 12.7x |
| Price to FCF | 14.8x |
| EV/FCF | 17.9x |
| PEG | 1.3 |
| FCF yield | 6.8% |
Historical Medians
Against its 10-year medians, its P/E is 2.6% below 15.1x, its P/S is 28.6% below 0.7x and its P/B is 4.3% below 2.3x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 14.7x | 14.4x | 15.1x |
| P/S | 0.5x | 0.7x | 0.7x |
| P/B | 2.2x | 2.8x | 2.3x |
Valuation History
Over the 10 year ends shown, its P/E ranged from 11.2x in 2024 to 18.8x in 2017.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $350.55 | 11.6x | 0.4x | 1.8x |
| 2024 | $368.90 | 11.2x | 0.5x | 2.1x |
| 2023 | $471.56 | 14.2x | 0.6x | 2.8x |
| 2022 | $512.97 | 17.7x | 0.8x | 3.4x |
| 2021 | $463.54 | 17.8x | 0.8x | 3.2x |
| 2020 | $321.09 | 14.3x | 0.7x | 2.4x |
| 2019 | $302.03 | 15.6x | 0.7x | 2.5x |
| 2018 | $262.63 | 16.5x | 0.7x | 2.4x |
| 2017 | $225.01 | 18.8x | 0.7x | 2.2x |
| 2016 | $143.77 | 13.1x | 0.4x | 1.5x |
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About ELV
What is ELV's forward P/E ratio?
Elevance Health has a forward P/E ratio of 14.3x.
Is ELV stock overvalued?
GNG's valuation label for ELV is Fairly valued. Its P/E of 14.7x compares with a median of 29.2x across 12 similar companies.
What is ELV's price to sales ratio?
Elevance Health has a price to sales ratio of 0.5x.
What is Elevance Health's average P/E ratio over 5 years?
Elevance Health's median P/E over the last 5 years is 14.4x, from 60 month-end values through Oct 2026.
What is ELV's PEG ratio?
Elevance Health has a PEG ratio of 1.3.
ELV pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts